Monopar Therapeutics (MNPR)

Last Three Months

27-Mar-24 -- 26-Jun-24

Time Period:

Three Months
|
Year

0 Net Amount

Buy:	0	--
Sell:	0	--

Company Sentiment

Other

Other

Sentiment Breakdown by Insider

0

(3)

0

(2)

0

(1)

10

0

2

+1

0

+2

0

+3

Two Year Chart

27-Jun-22 -- 26-Jun-24

Price ($)

Two Year Stock Price Chart

Sentiment

Buy & Sell Volume ($)

Two Year Insider Trading Volume Chart

Recent Insider Trades

Last Transaction		Last Three Months
SEC Filing	Transaction	Insider	Sentiment	Company	Holdings Change	Buy Amount	Sell Amount	Buy Price Range	Sell Price Range
30-May-24 6:10 PM View:	28-May-24 Exercise (in-the money or at-the-money) $84.00	Robinson Chandler Chief Executive Officer Director		Monopar Therapeutics - MNPR	2% 4.43M to 4.53M	0	0	--	--	Show Txns Hide Txns

21-Jun-24 5:16 PM View:	20-Jun-24 Purchase $15.25K	Cittadine Andrew Chief Operating Officer		Monopar Therapeutics - MNPR	260% 51.77K to 186.13K	0	0	--	--	Show Txns Hide Txns

02-Apr-24 8:33 PM View:	31-Mar-24 Payment of Exercise ($2.78K)	Tsuchimoto Kim R Chief Financial Officer Director		Monopar Therapeutics - MNPR	13% 44.6K to 50.47K	0	0	--	--	Show Txns Hide Txns